Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00622206Phase 2Completed
A Phase 2 trial of ritonavir in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00622206.